Schedule 13G ownership disclosure
ANIKA THERAPEUTICS INC
Common Stock · CUSIP: 035255108
Event date: 2025-09-30
- Filing-level shares
- 793,359
- Percent of class
- 5.5%
- BlackRock Portfolio Management LLC
Shares: 793,359 · Class: 5.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002052113-25-003599
- Form type
- SCHEDULE 13G
- Filer
- Anika Therapeutics, Inc.
- CIK
- CIK 898437
- Filed
- Oct 17, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership